Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes
✍ Scribed by Yasuhiko Kitadai; Michiyo Kodama; Songde Cho; Tsuyoshi Kuroda; Takehiko Ochiumi; Shigeru Kimura; Shinji Tanaka; Shunji Matsumura; Wataru Yasui; Kazuaki Chayama
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- French
- Weight
- 333 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The spread of tumor cells to regional lymph nodes is an early event of gastric cancer metastasis. In our study, we assessed the expression of lymphangiogenic factors and lymphatic endothelial markers in gastric carcinoma tissues and compared expression levels with the status of lymph node metastasis. We also examined the correlation between lymphatic vessel density (LVD) in primary tumors and lymph node metastasis. Paired biopsy samples (tumor and corresponding normal mucosa) of gastric tissue were obtained from 39 patients with gastric carcinoma. The expression of VEGF‐C, VEGF‐D, VEGFR‐3 and podoplanin mRNAs was assessed by real‐time quantitative PCR. The expression of VEGF‐C (but not of VEGF‐D) was significantly greater in patients with lymph node metastasis than in those without metastasis. The expression of lymphatic endothelial markers VEGFR‐3 and podoplanin was also significantly greater in the node‐positive group. LVD, as assessed by immunohistochemistry for podoplanin, was correlated with lymph node metastasis. These results indicate that quantitative analysis of lymphangiogenic markers in gastric biopsy specimens may be useful in predicting metastasis of gastric cancer to regional lymph nodes. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Background: Neck metastasis is a major prognostic factor of head and neck carcinoma, but its preoperative detection is currently unreliable. molecular markers of the metastatic potential of a carcinoma would help to avoid unnecessary neck dissection in patients with nonmetastatic cancer. ## Met